This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castor, J.
Right arrow Articles by Jerome, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castor, J.
Right arrow Articles by Jerome, K. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2007, p. 2681-2683, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00526-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Rapid Detection Directly from Patient Serum Samples of Human Cytomegalovirus UL97 Mutations Conferring Ganciclovir Resistance{triangledown}

Jared Castor,1 Linda Cook,1 Lawrence Corey,1,2 and Keith R. Jerome1,2*

Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington 98195,1 Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 981092

Received 8 March 2007/ Returned for modification 14 April 2007/ Accepted 20 May 2007

Ganciclovir-resistant cytomegalovirus can cause disease and death in transplant recipients. We describe here a rapid PCR- and sequencing-based assay for ganciclovir resistance that can be performed in 1 to 2 working days directly from patient specimens, without the need for amplification of the virus by cell culture. An evaluation of 120 sequential samples submitted for clinical testing revealed a variety of silent and amino acid mutations.

* Corresponding author. Mailing address: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, D3-100, Seattle, WA 98109. Phone: (206) 667-6793. Fax: (206) 667-4411. E-mail: kjerome{at}fhcrc.org

{triangledown} Published ahead of print on 30 May 2007.

Journal of Clinical Microbiology, August 2007, p. 2681-2683, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00526-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Allice, T., Busca, A., Locatelli, F., Falda, M., Pittaluga, F., Ghisetti, V. (2009). Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus. J Antimicrob Chemother 63: 600-608 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»